Inhibition of LPS-induced tumor necrosis factor-α production by colchicine and other microtubule disrupting drugs

Immunobiology

Volumn 195, Issue 4-5, 1996, Pages 624-639

  Li, Zhouya ^b   Davis, Gerald S ^b   Mohr, Carsten ^b   Nain, Marianne ^b   Gemsa, Diethard ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COLCHICINE; LIPOPOLYSACCHARIDE; MESSENGER RNA; NOCODAZOLE; TUMOR NECROSIS FACTOR ALPHA; VINBLASTINE; VINCRISTINE;

ANIMAL CELL; CONFERENCE PAPER; CONTROLLED STUDY; GENE EXPRESSION; IMMUNE RESPONSE; MACROPHAGE; MICROTUBULE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; RAT;

EID: 0029828776     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(96)80027-1     Document Type: Conference Paper

References (39)

1. OLD, L. J. 1985. Tumor necrosis factor (TNF). Science 230: 630.
2. GIFFORD, G. E., and D. A. FLICK. 1987. Natural production and release of tumor necrosis factor. In: Tumor Necrosis Factor and Related Cytokines. Vol. 131. Ciba Foundation Symposium, p. 3.
3. BEUTLER, B., and A. CERAMI. 1988. Tumor necrosis factor, cachexia, shock, and inflammation: a common mediator. Ann. Rev. Biochem. 57: 505.
4. SHERRY, B., and A. CERAMI. 1988. Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses. J. Cell Biol. 107: 1269.
5. TRACEY, K. J., H. WEI, K. R. MONOGUE, J. FONG, D. G. HESSE, H. T. NGUYEN, G. C. KUO, B. BEUTLER, R. S. CONTRAN, A. CERAMI, and S. F. LOWRY. 1988. Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. J. Exp. Med. 167: 1211.
6. BEUTLER, B. 1990. The tumor necrosis factors: cachectin and lymphotoxin. Hospital Practice 25/2: 45.
7. CHOUAIB, S., D. BRANELLEC, and W. A. BUURMAN. 1991. More insights into the complex physiology of TNF. Immunol. Today 12: 141.
8. COLLART, M. A., D. BELIN, J. D. VASSALLI, S. DE KOSSODO, and P. VASSALLI. 1986. γ-interferon enhances macrophage transcription of the tumor necrosis factor/ cachevtin, interleukin-1, and urokinase genes, which are controlled by short-lived repressors. J. Exp. Med. 164: 2113.
9. SARIBAN, E., K. IMAMURA, R. LUEBBERS, and D. KUFE. 1988. Transcriptional and post-transcriptional regulation of tumor necrosis factor gene expression in human monocytes. J. Clin. Invest. 81: 1506.
10. BURCHETT, S. K., W. M. WEAVER, J. A. WESTALL, A. LARSEN, S. KRONHEIM, and C. B. WILSON. 1988. Regulation of tumor necrosis factor/cachectin and IL-1 secretion in human mononuclear phagocytes. J. Immunol. 140: 3473.
11. KRIEGLER, M., C. PEREZ, K. DEFAY, I. ALBERT, and S. D. LU. 1988. A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell 53: 45.
12. SHAKHOV, A. N., M. A. COLLART, P. VASSALLI, S. A. NEDOSPASOV, and C. V. JONGENEEL. 1990. κB-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor α gene in primary macrophages. J. Exp. Med. 171: 35.
13. HAN, J., T. BROWN, and B. BEUTLER. 1990. Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level. J. Exp. Med. 171: 465.
14. GONG, J.-H., H. SPRENGER, F. HINDER, A. BENDER, A. SCHMIDT, S. HORCH, M. NAIN, and D. GEMSA. 1991. Influenza A virus infection of macrophages: enhanced tumor necrosis factor-α (TNF-α) gene expression and lipopolysaccharide-triggered TNF-α release. J. Immunol. 147: 3507.
15. VILCEK, J., and T. H. LEE. 1991. Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J. Biol. Chem. 266: 7313.
16. GEMSA, D., W. KRAMER, M. BRENNER, G. TILL, and K. RESCH. 1980. Induction of prostaglandin E release from macrophages by colchicine. J. Immunol. 124: 376.
17. SKITZ, M., W. DEIMANN, N. GRAM, W. HUNSTEIN, and D. GEMSA. 1982. Characterization of blood mononuclear cells of rheumatoid arthritis patients. I. Depressed lymphocyte proliferation and enhanced prostanoid release from monocytes. Clin. Immunol. Immunopathol. 25: 405.
18. 2 regulates macrophage-derived tumor necrosis factor gene expression. J. Biol. Chem. 263: 5380.
19. 2 and cyclic nucleotides. J. Immunol. 141: 2388.
20. ALLEN, J. N., D. J. HERZYK, and M. D. WEWERS. 1991. Colchicine has opposite effects on interleukin-1β and tumor necrosis factor-α production. Am. J. Physiol. 261: L315.
21. DING, A. H., F. PORTEU, E. SANCHEZ, and C. F. NATHAN. 1990. Downregulation of tumor necrosis factor receptors on macrophages and endothelial cells by microtubule depolymerizing agents. J. Exp. Med. 171: 715.
22. GEMSA, D., C. H. WOO, H. H. FUDENBERG, and R. SCHMID. 1973. Erythrocyte catabolism by macrophages in vitro: the effect of hydrocortisone on erythrophagocytosis and on the induction of heme oxygenase. J. Clin. Invest. 52: 812.
23. LOVETT, D., B. KOZAN, M. HADAM, K. RESCH, and D. GEMSA. 1986. Macrophage cytotoxicity: interleukin 1 as a mediator of tumor cytostasis. J. Immunol. 136: 340.
24. GEMSA, D., W. KRAMER, I. NAPIERSKI, E. BÄRLIN, G. TILL, and K. RESCH. 1981. Potentiation of macrophage tumor cytostasis by tumor-induced ascites. J. Immunol. 126: 2143.
25. NAIN, M., F. HINDER, J.-H. GONG, A. SCHMIDT, A. BENDER, H. SPRENGER, and D. GEMSA. 1990. Tumor necrosis factor-α production of influenza A virus-infected macrophages and potentiating effect of lipopolysaccharides. J. Immunol. 145: 1921.
26. 2 from macrophages of rats with silicosis. Am. J. Respir. Cell Molec. Biol. 6: 390.
27. CHOMCZYNSKI, P., and N. SACCHI. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156.
28. BENDER, A., U. AMANN, R. JÄGER, M. NAIN, and D. GEMSA. 1993. Effect of granulocyte/macrophage colony-stimulating factor on human monocytes infected with influenza A virus: enhancement of virus replication, cytokine release and cytotoxicity. J. Immunol., 151: 5416.
29. TAVERNIER, J., L. FRANSEN, A. MARMENOUT, J. VAN DER HEYDEN, R. MUELLER, M.-R. RUYSSCHAERT, A. VAN VLIET, R. BAUDEN, and W. FIERS. 1987. Isolation and expression of the genes coding for mouse and human tumor necrosis factor (TNF) and biological properties of recombinant TNF. Lymphokines 13: 181.
30. WILSON, L., J. R. BAMBURG, S. B. MIZEL, L. M. GRISHAM, and K. M. CRESWELL. 1974. Interactions of drugs with microtubule proteins. Fed. Proc. 33: 158.
31. ZURIER, R. B., G. WEISSMANN, S. HOFSTEIN, S. KAMMERMAN, and H. H. TAI. 1974. Mechanisms of lysosomal enzyme release from human leukocytes. II. Effects of cAMP and cGMP, autonomic agonists, and agents which affect microtubule function. J. Clin. Invest. 53: 297.
32. ANTOINE, J.-C., M. MAURICE, G. FELDMANN, and S. AVRAMEAS. 1980. In vivo and in vitro effects of colchicine and vinblastine on the secretory process of antibody-producing cells. J. Immunol. 125: 1939.
33. MALAVISTA, S. E. 1975. The action of colchicine in acute gouty arthritis. Arthritis Rheum. 18 (Suppl.): 835.
34. BRANDWEIN, S. R., J. D. SIPE, E. TATSUTA, M. SKINNER, and A. S. COHEN. 1984. Colchicine in acute inflammation: stimulation of production of interleukin-1 and modulation of the acute phase serum amyloid A protein response. J. Rheumatol. 11: 597.
35. FERRUA, B., S. MANIE, A. DOGLIO, A. SHAW, S. SONTHONNAX, M. LIMOUSE, and L. SCHAFFAR. 1990. Stimulation of human interleukin 1 production and specific mRNA expression by microtubule-disrupting drugs. Cell. Immunol. 131: 391.
36. TARTAKOFF, A. M. 1983. Perturbation of vesicular traffic with the carboxylic ionophore monensin. Cell 32: 1026.
37. 2-mediated suppression of lipopolysaccharide-induced tumor necrosis factor alpha gene expression. Infect. Immun. 57: 2837.
38. TAFFET, S. M., K. J. SINGHEL, J. F. OVERHOLTZER, and S. A. SHURTLEFF. 1989. Regulation of tumor necrosis factor expression in a macrophage-like cell line by lipopolysaccharide and cyclic AMP. Cell. Immunol. 120: 291.
39. LI, Z., C. MOHR, G. S. DAVIS, M. NAIN, and D. GEMSA. Suppression of LPS-induced tumor necrosis factor-α gene expression by microtubule disrupting agents. Clinical Immunology and Immunopathology, submitted.